Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3542 | 1884 | 37.9 | 76% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MPTP | Author keyword | 96 | 24% | 19% | 357 |
2 | MPP | Author keyword | 33 | 23% | 7% | 127 |
3 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | Author keyword | 31 | 31% | 4% | 81 |
4 | 1 METHYL 4 PHENYLPYRIDINIUM ION MPP | Author keyword | 29 | 73% | 1% | 22 |
5 | 1 METHYL 4 PHENYLPYRIDINIUM | Author keyword | 20 | 37% | 2% | 45 |
6 | 1 METHYL 4 PHENYLPYRIDINIUM ION | Author keyword | 16 | 53% | 1% | 21 |
7 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE MPTP | Author keyword | 12 | 35% | 1% | 28 |
8 | MPTP 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | Author keyword | 7 | 38% | 1% | 15 |
9 | ALTERNAT MED EXPT THER EUT | Address | 7 | 64% | 0% | 7 |
10 | DRUG METAB THER EUT | Address | 5 | 47% | 0% | 8 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE MPTP | 148 | 43% | 14% | 267 |
2 | 1 METHYL 4 PHENYL 1 2 5 6 TETRAHYDROPYRIDINE | 132 | 77% | 5% | 89 |
3 | N METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | 98 | 63% | 5% | 98 |
4 | MPP | 86 | 50% | 7% | 125 |
5 | 1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE | 78 | 36% | 9% | 177 |
6 | MPTP | 65 | 22% | 14% | 259 |
7 | 1 METHYL 4 PHENYLPYRIDINIUM ION MPP | 58 | 66% | 3% | 54 |
8 | DOPAMINERGIC NEUROTOXICITY | 51 | 38% | 6% | 107 |
9 | 1 METHYL 4 PHENYLPYRIDINIUM | 38 | 36% | 5% | 85 |
10 | CHRONIC PARKINSONISM | 37 | 58% | 2% | 43 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ADVANCES IN OUR UNDERSTANDING OF THE MECHANISMS OF THE NEUROTOXICITY OF MPTP AND RELATED-COMPOUNDS | 1993 | 439 | 115 | 66% |
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety | 2001 | 212 | 39 | 79% |
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease | 2001 | 188 | 129 | 61% |
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP | 2004 | 236 | 71 | 46% |
MPTP TOXICITY - IMPLICATIONS FOR RESEARCH IN PARKINSONS-DISEASE | 1988 | 215 | 61 | 85% |
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE | 2012 | 75 | 308 | 20% |
MPTP MECHANISMS OF NEUROTOXICITY AND THEIR IMPLICATIONS FOR PARKINSONS-DISEASE | 1991 | 183 | 121 | 89% |
Experimental models of Parkinson's disease | 2001 | 327 | 100 | 29% |
Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man | 1996 | 326 | 190 | 38% |
Neurochemical findings in the MPTP model of Parkinson's disease | 2001 | 146 | 95 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALTERNAT MED EXPT THER EUT | 7 | 64% | 0.4% | 7 |
2 | DRUG METAB THER EUT | 5 | 47% | 0.4% | 8 |
3 | RAJA MUTHAIAH MED | 4 | 75% | 0.2% | 3 |
4 | BIOCHEM MOL BIOL NEUROL | 2 | 67% | 0.1% | 2 |
5 | HARVEY W PETERS STUDY PARKINSONS DIS | 2 | 67% | 0.1% | 2 |
6 | MEF FISIOL | 2 | 67% | 0.1% | 2 |
7 | BEHAV NEUROSCI PATHOL | 2 | 31% | 0.3% | 5 |
8 | GEORGE MARYLOU BOONE PARKINSONS DIS MOVEMENT | 1 | 100% | 0.1% | 2 |
9 | NEUROL SERV WARREN 408 | 1 | 100% | 0.1% | 2 |
10 | UMR 5543BASAL GANG | 1 | 33% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000173793 | SALSOLINOL//NORSALSOLINOL//1 METHYL 1 2 3 4 TETRAHYDROISOQUINOLINE |
2 | 0.0000153510 | NEUROMELANIN//AMINOCHROME//5 S CYSTEINYLDOPAMINE |
3 | 0.0000124950 | ROTENONE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//3 4 DIHYDROXYPHENYLACETALDEHYDE |
4 | 0.0000111562 | NEUROPHARMACOL SECT//NEUROANAT EXPT NEUROL//PHARMACOL CHEM |
5 | 0.0000104290 | MONOAMINE OXIDASE//MAO B//MONOAMINE OXIDASE B |
6 | 0.0000103249 | RASAGILINE//SELEGILINE//DEPRENYL |
7 | 0.0000073150 | FUNCTIONALIZED PIPERIDINES//TETRAHYDROPYRIDINES//POLYSUBSTITUTED PIPERIDINE |
8 | 0.0000068345 | AMINE ACCUMULATION//CATIONIZED POLYACRYLAMIDE//LONG TERM DEFICITS |
9 | 0.0000063983 | BUDIPINE//4 SUBSTITUTED ANILINES//LONG TERM ELECTROMYOGRAPHY |
10 | 0.0000062553 | SEROFENDIC ACID//BATIMENT PHARM//MALDI TOF IMAGING |